Health Bulletin 31/January/2024

Here are the top health news for the day:

HC orders Bengal Govt to establish medical board for rape survivors' pregnancy termination

In a significant development, the Calcutta High Court issued a directive on Monday, instructing the West Bengal government to constitute a medical board for the evaluation of a rape survivor's pregnancy, who is seeking termination due to the distressing incident.

The petitioner, a 27-year-old woman, is currently between 20 to 24 weeks into her pregnancy.

The petitioner's lawyer submitted before the court that she is suffering from grave mental trauma and as such the court may permit the medical termination of the pregnancy which was stated to be between 20 and 24 weeks. Justice Sabyasachi Bhattacharyya directed the state government to form a medical board to examine the condition of the 27-year-old petitioner.

For the full story, check out the link given below:

Set Up Medical Board To Examine Rape Survivor's Pregnancy Termination: HC Directs West Bengal Govt

CDSCO panel approves Sun Pharma to study leuprolide acetate for depot suspension

The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the bioequivalence study of anticancer drug Leuprolide acetate depot suspension 7.5mg/vial (1 Month Depot), a man-made form of gonadotropin-releasing hormone (GnRH) that is used in men to treat the symptoms of prostate cancer.

This came after the drug major Sun Pharma presented bioequivalence study protocol No. C1B03530, Version No. 01 dated 18-Sep-2023.

For the full story, check out the link given below:

Sun Pharma Gets CDSCO Panel Nod To Study Leuprolide Acetate For Depot Suspension

Rajasthan HC upholds NMC MARB on Medical admissions cancellation

While considering the pleas challenging the Medical Assessment and Rating Board's (MARB) decision to cancel UG and PG medical admissions in four medical colleges in Rajasthan, the High Court bench ruled that the MARB of the National Medical Commission (NMC) does not have the authority to cancel admissions of students into medical colleges retrospectively.

The bench comprising Justice Arun Monga opined that although MARB can recommend reducing the future intake capacity of medical institutes that consistently fail to meet the minimum standards, it does not mean that intake can be reduced retrospectively or admissions once granted can be stopped retrospectively.

For the full story, check out the link given below:

NMC MARB Cannot Retrospectively Cancel Medical Admissions: Rajasthan HC